Cell IDx’s UltraPlex platform technology provides everything you need for multiplexed IHC-based immune-profiling of tissue biomarkers. One technology from research to clinical — from staining to analysis in one day.
News & Technology Updates
Cell IDx is pleased to announce the co-authorship and use of our UltraPlex mxIF technology for profiling of the TME in this important study
A Phase I trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6/E7 oncogenes after chemoradiation for cervical cancer. View a summary of this paper by Hasan et al.
Products & Services
Multiplex Chromogenic (mxIHC)
Allows detection of 2–4 markers using primary antibodies from any species employing a single antigen retrieval step on an autostainer.
Immuno-Oncology Multiplexing
Phenotype infiltrating T cell subpopulations, B cells, and antigen-presenting cells, and quantitate expression of key molecules including checkpoint markers.
UltraPolymer Detection
Highest sensitivity and specificity, low background secondary antibody HRP immunopolymers for all your IHC needs.
Services
Custom multiplex panel development , and section staining and imaging.
- For Research Use Only. Not for use in diagnostic procedures.